Search Ontology:
ChEBI
(2S,3R,4S,5R,6R)-2-[(3S,4R,5R,6S)-2,5-Dihydroxy-6-methyl-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- Term ID
- CHEBI:151963
- Synonyms
-
- beta-D-galacto-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->3)]-6-deoxy-L-galacto-hexopyranose
- Gal(b1-2)[Gal(b1-3)]Fuc
- WURCS=2.0/2,3,2/[a1221m-1x_1-5][a2112h-1b_1-5]/1-2-2/a2-b1_a3-c1
- Definition
- References
-
- GlyGen:G50616AZ
- GlyTouCan:G50616AZ
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (2S,3R,4S,5R,6R)-2-[(3S,4R,5R,6S)-2,5-Dihydroxy-6-methyl-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Phenotype where environments contain (2S,3R,4S,5R,6R)-2-[(3S,4R,5R,6S)-2,5-Dihydroxy-6-methyl-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Phenotype modified by environments containing (2S,3R,4S,5R,6R)-2-[(3S,4R,5R,6S)-2,5-Dihydroxy-6-methyl-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Human Disease / Model Data
Citations